Paasa Logo
Tonix Pharmaceuticals Holding Corp. logo
TNXPNASDAQMarket openCloses 4:00pm ET

Tonix Pharmaceuticals Holding Corp.

$9.81Last updated
-$0.06 (0.56%)Past day
Timezone

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is trading at $9.81, about ₹941 at today's USD/INR rate, as of 28 Sep 2026, 12:07 PM ET, down 0.56% today. Indian residents can buy Tonix Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$9.77
Previous close:$9.86
Volume:113.04K

Today's low

$9.73

Today's high

$9.84

52 week low

$9.40

52 week high

$25.52

TNXP opened at $9.77, closed previously at $9.86, and has traded between $9.40 and $25.52 over the past 52 weeks.

About

Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and commercialization of novel therapeutic agents and diagnostic tools, all aimed at combating human illnesses and easing patient discomfort. The company boasts a comprehensive pipeline of potential treatments spanning several key medical fields: immunology, rare conditions, infectious diseases, and central nervous system (CNS) disorders. In the realm of immunology, Tonix is progressing with biologics designed to address organ transplant rejection, various autoimmune diseases, and certain forms of cancer. A prominent candidate here is TNX-1500, a humanized monoclonal antibody targeting CD40-ligand, which is being investigated for its utility in preventing both allograft and xenograft rejection, as well as in treating autoimmune disorders. Its rare disease initiatives include TNX-2900, a specific treatment candidate for Prader-Willi syndrome. The infectious disease segment features a diverse array of programs: TNX-801, a vaccine designed to offer protection against smallpox and monkeypox. TNX-1840 and TNX-1850, which are live virus vaccines based on the company's recombinant pox vaccine (RPV) platform, targeting COVID-19. TNX-3500, a small molecule antiviral drug for the treatment of acute COVID-19. TNX-102 SL, a small molecule medication under investigation for Long COVID, a persistent post-acute COVID-19 condition. Finally, the CNS portfolio encompasses both small molecules and biologics intended to manage pain, neurological conditions, psychiatric ailments, and addiction. Notably, TNX-102 SL is also in mid-Phase 3 development for alleviating fibromyalgia symptoms. Other CNS candidates include TNX-1900, which is being developed to prevent migraine headaches, and TNX-1300, a biologic aimed at treating cocaine intoxication. The company was established in 2007 and maintains its headquarters in Chatham, New Jersey.

Country
US
CEO
Seth Lederman
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
142
Sector
Healthcare
IPO date
10/05/2012

Key statistics

Avg. volume

508.89K

Market cap

$156.30M

P/E Ratio

-0.74

Price-to-sales ratio

5.37

Enterprise value

-$18.58M

Free cash flow yield

-102.24%

Debt-to-equity ratio

0.01

Return on equity

-68.99%

ROIC

-74.00%

Beta

1.75

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$13.11M

Earnings per share

-$14.57

Free cash flow

-$103.21M

Net profit margin

-548.64%

Gross margin

80.25%

EBITDA

-$122.01M

Revenue growth

29.85%

Similar securities

This is not an investment recommendation

How to buy Tonix Pharmaceuticals from India

Indian residents can buy Tonix Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Tonix Pharmaceuticals and place an order

    Find Tonix Pharmaceuticals by name or by its ticker, TNXP, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Tonix Pharmaceuticals trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Tonix Pharmaceuticals position in USD and INR. Tonix Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Tonix Pharmaceuticals from India

Trading and taxes when buying Tonix Pharmaceuticals from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneTonix Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Tonix Pharmaceuticals stock?

Yes. Tonix Pharmaceuticals (TNXP) has been listed on NASDAQ since 2012, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Tonix Pharmaceuticals share cost in rupees?

One Tonix Pharmaceuticals share is $9.81 — about ₹941 at a USD/INR rate of 95.93 on 27 Sep 2026. Both the Tonix Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Tonix Pharmaceuticals from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Tonix Pharmaceuticals?

Yes. One Tonix Pharmaceuticals share is $9.81, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Tonix Pharmaceuticals.

How are gains on Tonix Pharmaceuticals shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Tonix Pharmaceuticals price. Paasa issues a capital-gains statement for your return.

Does Tonix Pharmaceuticals pay a dividend?

No. Tonix Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Tonix Pharmaceuticals from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Tonix Pharmaceuticals shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Tonix Pharmaceuticals shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Tonix Pharmaceuticals holding, its cost and its closing value.

How do I sell Tonix Pharmaceuticals and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.